BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 27890451)

  • 1. Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.
    Krismer F; Pinter B; Mueller C; Mahlknecht P; Nocker M; Reiter E; Djamshidian-Tehrani A; Boesch SM; Wenning GK; Scherfler C; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2017 Feb; 35():36-41. PubMed ID: 27890451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
    Watanabe Y; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Uchiyama T; Kadowaki T; Matsubara T; Hirata K
    Intern Med; 2017 Nov; 56(21):2871-2878. PubMed ID: 28943542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.
    Borm CDJM; Krismer F; Wenning GK; Seppi K; Poewe W; Pellecchia MT; Barone P; Johnsen EL; Østergaard K; Gurevich T; Djaldetti R; Sambati L; Cortelli P; Petrović I; Kostić VS; Brožová H; Růžička E; Marti MJ; Tolosa E; Canesi M; Post B; Nonnekes J; Bloem BR;
    Parkinsonism Relat Disord; 2018 Nov; 56():33-40. PubMed ID: 29910157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finger tapping analysis in patients with Parkinson's disease and atypical parkinsonism.
    Djurić-Jovičić M; Petrović I; Ječmenica-Lukić M; Radovanović S; Dragašević-Mišković N; Belić M; Miler-Jerković V; Popović MB; Kostić VS
    J Clin Neurosci; 2016 Aug; 30():49-55. PubMed ID: 27343040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease.
    Mahlknecht P; Pechlaner R; Boesveldt S; Volc D; Pinter B; Reiter E; Müller C; Krismer F; Berendse HW; van Hilten JJ; Wuschitz A; Schimetta W; Högl B; Djamshidian A; Nocker M; Göbel G; Gasperi A; Kiechl S; Willeit J; Poewe W; Seppi K
    Mov Disord; 2016 Sep; 31(9):1408-13. PubMed ID: 27159493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
    Mangesius S; Mariotto S; Ferrari S; Pereverzyev S; Lerchner H; Haider L; Gizewski ER; Wenning G; Seppi K; Reindl M; Poewe W
    Parkinsonism Relat Disord; 2020 Aug; 77():57-63. PubMed ID: 32622301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
    Suzuki M; Hashimoto M; Yoshioka M; Murakami M; Kawasaki K; Urashima M
    BMC Neurol; 2011 Dec; 11():157. PubMed ID: 22192419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China.
    Huang SF; Chen K; Wu JJ; Liu FT; Zhao J; Lin W; Guo SS; Wang YX; Wang Y; Luo SS; Sun YM; Ding ZT; Yu H; Wang J
    PLoS One; 2016; 11(8):e0160199. PubMed ID: 27483429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
    Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
    J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
    Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory function combined with morphology distinguishes Parkinson's disease.
    Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y
    Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended testing across, not within, tasks raises diagnostic accuracy of smell testing in Parkinson's disease.
    Boesveldt S; de Muinck Keizer RJ; Knol DL; Wolters ECh; Berendse HW
    Mov Disord; 2009 Jan; 24(1):85-90. PubMed ID: 18855928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfaction in Neuropathologically Defined Progressive Supranuclear Palsy.
    Shill HA; Zhang N; Driver-Dunckley E; Mehta S; Adler CH; Beach TG
    Mov Disord; 2021 Jul; 36(7):1700-1704. PubMed ID: 33755262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of odor identification test in Parkinson's disease in China: a matched case-control study.
    Chen W; Chen S; Kang WY; Li B; Xu ZM; Xiao Q; Liu J; Wang Y; Wang G; Chen SD
    J Neurol Sci; 2012 May; 316(1-2):47-50. PubMed ID: 22364958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR; Lees AJ
    Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odor Identification Testing Can Assist in the Clinical Distinction Between Psychiatric Disorders and Neurological/Neurodegenerative Disorders.
    Pachi I; Evans AH; Loi SM; Eratne D; Malpas CB; Walterfang M; Farrand S; Kelso W; Stefanis L; Velakoulis D
    Alzheimer Dis Assoc Disord; 2021 Jul-Sep 01; 35(3):244-249. PubMed ID: 33769989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.